Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Vor Biopharma Inc. - Common Stock
(NQ:
VOR
)
1.370
+0.040 (+3.01%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vor Biopharma Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
Vor Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update
March 20, 2024
From
Vor Biopharma
Via
GlobeNewswire
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
March 05, 2024
From
Vor Biopharma
Via
GlobeNewswire
Vor Bio to Participate in Upcoming Investor Conferences
March 04, 2024
From
Vor Biopharma
Via
GlobeNewswire
The Latest Analyst Ratings for Vor Biopharma
August 14, 2023
Via
Benzinga
What 11 Analyst Ratings Have To Say About Vor Biopharma
June 12, 2023
Via
Benzinga
Vor Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
February 07, 2024
From
Vor Biopharma
Via
GlobeNewswire
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 02, 2024
From
Vor Biopharma
Via
GlobeNewswire
Vor Bio Doses First AML Patient with VCAR33 (ALLO) and Provides Corporate Update
January 17, 2024
From
Vor Biopharma
Via
GlobeNewswire
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 21, 2023
From
Vor Biopharma
Via
GlobeNewswire
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 01, 2023
From
Vor Biopharma
Via
GlobeNewswire
Vor Bio to Participate in the JMP Securities Hematology and Oncology Summit
November 27, 2023
From
Vor Biopharma
Via
GlobeNewswire
Vor Bio Presents Positive Data Update on Trem-cel at HSCT² Conference
November 09, 2023
From
Vor Biopharma
Via
GlobeNewswire
Vor Bio Reports Third Quarter 2023 Financial Results and Provides Company Update
November 07, 2023
From
Vor Biopharma
Via
GlobeNewswire
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 03, 2023
From
Vor Biopharma
Via
GlobeNewswire
Vor Bio to Participate in Upcoming Investor Conferences
November 03, 2023
From
Vor Biopharma
Via
GlobeNewswire
Multiple Clinical and Preclinical Presentations at ASH 2023 Highlight Vor Bio’s Novel eHSC and CAR-T Platform
November 02, 2023
From
Vor Biopharma
Via
GlobeNewswire
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
October 03, 2023
From
Vor Biopharma
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Tuesday
October 03, 2023
On Tuesday, 647 companies set new 52-week lows.
Via
Benzinga
Vor Bio to Participate in Upcoming Investor Conferences
September 25, 2023
From
Vor Biopharma
Via
GlobeNewswire
Vor Bio to Participate in Upcoming Investor Conferences
August 30, 2023
From
Vor Biopharma
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Thursday
September 21, 2023
During the session on Thursday, 461 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
September 19, 2023
During Tuesday's session, 275 companies made new 52-week lows.
Via
Benzinga
Vor Bio Reports Second Quarter 2023 Financial Results and Provides Company Update
August 10, 2023
From
Vor Biopharma
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Friday
August 11, 2023
During the Friday's sesion, 157 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
August 10, 2023
On Thursday, 128 companies set new 52-week lows.
Via
Benzinga
Vor Bio to Participate in the Wedbush PacGrow Healthcare Conference
August 01, 2023
From
Vor Biopharma
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Wednesday
July 05, 2023
Wednesday's session saw 43 companies set new 52-week lows.
Via
Benzinga
Top 5 Health Care Stocks That Could Lead To Your Biggest Gains In July
July 05, 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
Vor Bio's Trem-cel Shows Early Encouraging Data In Leukemia Patients
June 09, 2023
Vor Biopharma Inc (NASDAQ: VOR) presented updated data from patients treated in the VBP101 Phase 1/2a study of trem-cel (formerly VOR33) in
Via
Benzinga
Successful Primary Engraftment of Trem-cel in First Five AML Patients Demonstrates Promise of Vor Bio’s Platform
June 09, 2023
From
Vor Biopharma
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.